We also suggest to include Batf2 as therapeutic target against cancer as Batf2 has been shown as a novel tumor suppresser gene, inhibiting growth of cancer cells [5, 71–73] through repression of hepatocyte growth factor receptor / MET signaling (Figure 1D) [74]. This evidence concerns the gene MET and cancer.